Creative Planning Nuvation Bio Inc. Transaction History
Creative Planning
- $116 Billion
- Q2 2025
A detailed history of Creative Planning transactions in Nuvation Bio Inc. stock. As of the latest transaction made, Creative Planning holds 39,288 shares of NUVB stock, worth $91,148. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,288
Previous 10,703
267.07%
Holding current value
$91,148
Previous $18,000
322.22%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NUVB
# of Institutions
185Shares Held
162MCall Options Held
4.6KPut Options Held
154K-
Decheng Capital LLC Menlo Park, CA26MShares$60.2 Million12.81% of portfolio
-
Black Rock Inc. New York, NY16.2MShares$37.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.9MShares$36.9 Million0.0% of portfolio
-
Omega Fund Management, LLC Boston, MA13.1MShares$30.3 Million47.43% of portfolio
-
Laurion Capital Management LP New York, NY9.87MShares$22.9 Million0.45% of portfolio
About Nuvation Bio Inc.
- Ticker NUVB
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 217,244,000
- Market Cap $504M
- Description
- Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-422, a small molecule inhibitor targeting cyclin-dependent kinase (CDK)2, CDK4, and CDK6. It is also developing NUV-868, a selective oral small molecule BET inhibitor that e...